(RTTNews) - Revelation Biosciences, Inc. (REVB), a clinical-stage life sciences company, announced on Monday that the FDA has accepted its Investigational New Drug (IND) application for Gemini, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback